Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank14
3Y CAGR-28.1%
5Y CAGR-19.5%
Year-over-Year Change
Research and development spending
3Y CAGR
-28.1%/yr
vs +61.8%/yr prior
5Y CAGR
-19.5%/yr
Recent deceleration
Acceleration
-90.0pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $14.36M | -53.8% |
| 2023 | $31.05M | -22.0% |
| 2022 | $39.83M | +3.0% |
| 2021 | $38.67M | +10.9% |
| 2020 | $34.86M | -17.7% |
| 2019 | $42.38M | +151.5% |
| 2018 | $16.85M | +199.0% |
| 2017 | $5.64M | - |